Elenco degli articoli con argomento «linfoma»
Dermatologia02 mag 2024
Classifications of cutaneous lymphomas and lymphoproliferative disorders
The classification of primary cutaneous lymphomas and lymphoproliferative disorders (LPD)
03 lug 2023
Primary Cutaneous B-Cell Lymphomas
Most primary cutaneous lymphomas consist of T-cell lymphomas or small cell lymphomas
22 mag 2023
An update on viral-induced cutaneous
Viral-induced cutaneous T-cell lymphomas are an uncommon group of lymphoproliferative disorders characterized by a viral infection
19 dic 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas
Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma (CTCL) after at least one previous systemic treatment.
28 set 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas
Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma
11 lug 2022
Dermatoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas
Limited data on dermatoscopy of nodular/plaque-type T-/B-cell primary cutaneous lymphomas (PCLs) is available.
04 lug 2022
Dermoscopic spectrum of mycosis fungoides
The dermoscopic features of classic patch stage mycosis fungoides (MF) have been described
08 nov 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome Part II
Primary cutaneous T-cell lymphomas (CTCLs) other than mycosis fungoides (MF) and Sézary syndrome (SS) encompass a heterogenous group of non-Hodgkin lymphomas
08 nov 2021
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome Part I
Primary cutaneous T-cell lymphomas (CTCLs) are defined as lymphomas with a T-cell phenotype that present in the skin without evidence of systemic or extracutaneous disease at initial presentation
13 apr 2021
Association Between Topical Calcineurin Inhibitor
Topical calcineurin inhibitors (TCIs) are commonly used as second-line treatment for atopic dermatitis.
26 gen 2021
Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides
Mycosis fungoides (MF) comprises 54% of cutaneous T cell lymphomas. Although the etiology is unknown, prior studies have shown that MF is more common in males than females, with greater incidence in African Americans (AAs).
30 ago 2020
Primary Cutaneous B-Cell Lymphomas: An Update
Primary cutaneous B-cell lymphomas (PCBCLs) comprise a group of extranodal B-cell non-Hodgkin lymphomas B-cell derived, which primarily involve the skin without evidence of extracutaneous disease at the time of diagnosis.
07 gen 2020
Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience
Atopic dermatitis (AD) is one of the most common cutaneous inflammatory diseases both in adults and in children.
15 set 2018
Dermoscopy of Lymphomas and Pseudolymphomas
Dermatol Clin. 2018 Oct;36(4):377-388
30 apr 2018
Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides
Position paper from the Italian Task Force for Cutaneous Lymphoma Task Force (Commissione Linfomi Cutanei) of Lymphoma Italian Foundation (Fondazione Italiana Linfomi, FIL).
20 mar 2017
FDA Approves Pembrolizumab for Certain Patients With Hodgkin Lymphoma
The US Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab (Keytruda) for the treatment of adult and paediatric patients with refractory classical Hodgkin lymphoma (cHL), or those who have relapsed after 3 or more prior lines of therapy
06 nov 2015
Dalle terapie contro psoriasi e artrite reumatoide un aiuto contro il linfoma
Alcuni farmaci già approvati per il trattamento della psoriasi e dell'artrite reumatoide dall'agenzia americana che si occupa di regolamentare i medicinali, l'Fda, potrebbero dare un contributo importante contro un tipo di linfoma raro e spesso letale
17 mag 2005
An Illustrated Guide to Skin Lymphoma
Testo atlante che combina magistralmente la clinica con l'istopatologia, la diagnosi ed il management dei linfomi cutanei. Seconda edizione